Stoiber F - Search Results

1

Austrian recommendations on Targeted Hormone Therapy for metastatic, castration-resistant prostate cancer.

Ponholzer A, Loidl W, Bektic J, Dorfinger K, Hruby S, Jeschke K, Kramer G, Krause S, Ludvik G, Remzi M, Roider M, Stoiber F. Ponholzer A, et al. Among authors: stoiber f. Wien Klin Wochenschr. 2016 Feb;128(3-4):156-63. doi: 10.1007/s00508-015-0945-x. Epub 2016 Feb 1. Wien Klin Wochenschr. 2016. PMID: 26831188

2

Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml?

Heinisch M, Dirisamer A, Loidl W, Stoiber F, Gruy B, Haim S, Langsteger W. Heinisch M, et al. Among authors: stoiber f. Mol Imaging Biol. 2006 Jan-Feb;8(1):43-8. doi: 10.1007/s11307-005-0023-2. Mol Imaging Biol. 2006. PMID: 16315004

3

Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study.

Beheshti M, Vali R, Waldenberger P, Fitz F, Nader M, Loidl W, Broinger G, Stoiber F, Foglman I, Langsteger W. Beheshti M, et al. Among authors: stoiber f. Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1766-74. doi: 10.1007/s00259-008-0788-z. Epub 2008 May 9. Eur J Nucl Med Mol Imaging. 2008. PMID: 18465129 Clinical Trial.

4

[How to use PSA in 2009].

Ponholzer A, Stoiber F, Loidl W, Rauchenwald M, Schramek P, Madersbacher S. Ponholzer A, et al. Among authors: stoiber f. Wien Med Wochenschr. 2009;159(21-22):515-20. doi: 10.1007/s10354-009-0718-0. Wien Med Wochenschr. 2009. PMID: 19997836 Review. German.

5

[Therapy of castration-resistant prostate cancer].

Rauchenwald M, Bauernhofer T, De Santis M, Füreder T, Höltl W, Kramer G, Krause S, Loidl W, Oismüller R, Reissigl A, Schmeller N, Stackl W, Stoiber F, Krainer M. Rauchenwald M, et al. Among authors: stoiber f. Wien Klin Wochenschr. 2012 Aug;124(15-16):538-51. doi: 10.1007/s00508-012-0206-1. Epub 2012 Jul 20. Wien Klin Wochenschr. 2012. PMID: 22815001 German.

6

Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study.

Kafka M, Giannini G, Artamonova N, Neuwirt H, Ofner H, Kramer G, Bauernhofer T, Luger F, Höfner T, Loidl W, Griessner H, Lusuardi L, Bergmaier A, Berger A, Winder T, Weiss S, Bauinger S, Krause S, Drerup M, Heinrich E, Schneider M, Madersbacher S, Vallet S, Stoiber F, Laimer S, Hruby S, Schachtner G, Nagele U, Lenart S, Ponholzer A, Pfuner J, Wiesinger C, Kamhuber C, Müldür E, Bektic J, Horninger W, Heidegger I. Kafka M, et al. Among authors: stoiber f. Clin Genitourin Cancer. 2024 Apr;22(2):458-466.e1. doi: 10.1016/j.clgc.2023.12.018. Epub 2024 Jan 4. Clin Genitourin Cancer. 2024. PMID: 38267304 Free article.

7

Chemotherapy for germ cell tumors relapsing after high-dose chemotherapy and stem cell support: a retrospective multicenter study of the Austrian Study Group on Urologic Oncology.

Pont J, Bokemeyer C, Harstrick A, Sellner F, Greinix H, Stoiber F. Pont J, et al. Among authors: stoiber f. Ann Oncol. 1997 Dec;8(12):1229-34. doi: 10.1023/a:1008286305312. Ann Oncol. 1997. PMID: 9496388 Free article.

8

Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study).

Schmidinger M, Bamias A, Procopio G, Hawkins R, Sanchez AR, Vázquez S, Srihari N, Kalofonos H, Bono P, Pisal CB, Hirschberg Y, Dezzani L, Ahmad Q, Jonasch E; PRINCIPAL Study Group. Schmidinger M, et al. Oncologist. 2019 Apr;24(4):491-497. doi: 10.1634/theoncologist.2018-0787. Epub 2019 Mar 13. Oncologist. 2019. PMID: 30867244 Free PMC article.

9

18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.

Beheshti M, Imamovic L, Broinger G, Vali R, Waldenberger P, Stoiber F, Nader M, Gruy B, Janetschek G, Langsteger W. Beheshti M, et al. Among authors: stoiber f. Radiology. 2010 Mar;254(3):925-33. doi: 10.1148/radiol.09090413. Radiology. 2010. PMID: 20177103

10

Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma.

De Santis M, Bokemeyer C, Becherer A, Stoiber F, Oechsle K, Kletter K, Dohmen BM, Dittrich C, Pont J. De Santis M, et al. Among authors: stoiber f. J Clin Oncol. 2001 Sep 1;19(17):3740-4. doi: 10.1200/JCO.2001.19.17.3740. J Clin Oncol. 2001. PMID: 11533096 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page